Sandoz-Valsartan Product Recall (2021-05-27)Health ProductsMay 27th, 2021 @ 12:00 AM
Basic Details
Issue: Product Safety
Category: Drugs
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Alert type: Drug Recall
Hazard classification: Type I
Summary
Product
Sandoz Valsartan 80mg Tablet
Products
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|---|---|---|---|---|
| KT9598 |
| B. Sandoz Valsartan 160mg Tablet | DIN 02356767 | Tablet | Valsartan 160mg |
| KT8923, KV6185 |
| C. Sandoz Valsartan 320mg Tablet | DIN 02356775 | Tablet | Valsartan 320mg |
| KT7180, KT9515 |
| A. Sandoz Valsartan 80mg Tablet | DIN 02356759 | Tablet | Valsartan 80mg |
Introduction
-
Sandoz Valsartan 80mg Tablet
-
Sandoz Valsartan 160mg Tablet
-
Sandoz Valsartan 320mg Tablet
Reason
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.
Depth of distribution
Retailers
For more information
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.